Clinical Trials List
Protocol NumberCMUH102-IRB-0401
Not yet recruiting
2014-05-01 - 2015-04-30
Phase II
Terminated2
-
Trial Applicant
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
6 participants
-
Global
6 participants
